STERIS STE Life Sciences: — Operating Income (Loss), Before Adjustments

Similar metrics at other companies

ASHLife Sciences — Operating Income

$35M+25.0%

DHRLife Sciences — Operating Income (Loss)

$225M+11.9%

VAT

VATELife Sciences — Income from operations

-$2.2M+26.7%

TMOLife Sciences Solutions — Operating Income (Loss)

$954M+14.4%

RCMTLife Sciences Data Solutions — Operating Income

$2.05M-3.7%

DCILife Sciences Segment — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

$6.8M+17.2%

Other financials

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

See full

Market cap$20.52B-9.4%

Enterprise value$22.17B-8.8%

P/E26.2×-8.8×

P/S3.5×-0.6×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept ste:OperatingIncomeLossBeforeAdjustments.

The official record: STERIS’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's life sciences: — operating income (loss), before adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's life sciences: — operating income (loss), before adjustments?: STERIS (STE) reported life sciences: — operating income (loss), before adjustments of $61.8M in Q4 2025.
What does life sciences: — operating income (loss), before adjustments mean?: This metric represents the raw operating performance of the Life Sciences segment before any non-recurring or special adjustments are applied. It provides a baseline view of the segment's core operational performance without the impact of one-time charges or accounting reclassifications.